Diversity & Inclusion
Skadden is advising M7 on the launch of its first Central European fund, M7 Central European Real Estate Fund 1 (M7 CEREF I).
Skadden is representing Boral Limited of Australia in its $2.6 billion acquisition of U.S.-based Headwaters Incorporated.
The firm is advising LifeLock, Inc. on its $2.3 billion acquisition by Symantec Corp.
Skadden is representing Ultrapar Participações S.A. in its $820 million acquisition of Liquigás Distribuidora S.A. from Petrobras.
Skadden advised MorphoSys AG on the €115 million international private placement of more than 2.6 million new shares via an accelerated book-building transaction as well as the admission of the new shares to trading on the Frankfurt Stock Exchange.
Skadden is representing Too Faced co-founders Jerrod Blandino and Jeremy Johnson in the company's $1.45 billion acquisition by The Estée Lauder Companies.
Skadden represented PHH in connection with its November 2016 resolution of a matter with the New York Department of Financial Services relating to mortgage loan origination and servicing activities between 2010 and 2014.
Skadden is advising Windstream Holdings, Inc. on its $1.1 billion merger with EarthLink Holdings Corp.
Skadden represented Valeant Pharmaceuticals International Inc. in resolving an investigation by the Federal Trade Commission into Valeant's May 2015 acquisition of Paragon Holdings I, Inc. and its subsidiary Paragon Vision Sciences.
Skadden represented Guangdong Kanghua Healthcare Co., Ltd., the operator of the largest private hospital in China, in its $114 million global offering, including an international offering and a Hong Kong public offering.